A detailed history of Wedgewood Investors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wedgewood Investors Inc holds 2,232 shares of ABBV stock, worth $445,284. This represents 0.49% of its overall portfolio holdings.

Number of Shares
2,232
Previous 2,232 -0.0%
Holding current value
$445,284
Previous $382,000 15.18%
% of portfolio
0.49%
Previous 0.46%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $28,922 - $33,308
-200 Reduced 8.22%
2,232 $355,000
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $336,369 - $403,395
2,432 New
2,432 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $353B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wedgewood Investors Inc Portfolio

Follow Wedgewood Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedgewood Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Wedgewood Investors Inc with notifications on news.